Adult Soft Tissue Sarcoma Clinical Trials

Find Adult Soft Tissue Sarcoma Clinical Trials Near You

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• All patients with known or suspected sarcoma who will have or have had tissue removed for therapeutic or diagnostic purposes.

• Patients will be entered without preference for any particular racial/ethnic group or gender.

• Patients may have received prior hormonal therapy, cytotoxic chemotherapy, irradiation, immunotherapy or surgical therapy.

• Tissue specimens must be large enough in quantity to allow routine pathologic analysis, with the research laboratory specimen removed from the residual specimen, which would otherwise be discarded. Optimal tissue amounts for snap freeze: Core biopsy - 2 tissue cores Incisional biopsy- 0.5 to 1.5 grams Resected sarcoma specimen- 1.0 to 50 grams depending on size of specimen Normal fat or muscle tissue - 0.5 to 4.0 grams (if available from resected sarcoma specimen) Optimal tissue amounts for RNA later Core biopsy - 2 tissue cores Incisional biopsy- 30 mg (three 3 x 3 x 3 mm cubes) Resected sarcoma specimen - 30 mg (three 3 x 3 x 3 mm cubes) Normal fat or muscle tissue - 30 mg (three 3 x 3 x 3 mm cube

Locations
United States
New Jersey
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth (Consent and Followup)
RECRUITING
Middletown
Memorial Sloan Kettering Bergen (Consent and Follow up)
RECRUITING
Montvale
New York
Memorial Sloan Kettering Commack (Consent and Follow-Up)
RECRUITING
Commack
Memorial Sloan Kettering Westchester (Consent and Followup)
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING
New York
Memorial Sloan Kettering Nassau (Consent and Followup)
RECRUITING
Rockville Centre
Contact Information
Primary
Samuel Singer, MD
212-639-2940
Backup
Aimee Crago, MD, PhD
Time Frame
Start Date: 2002-06
Estimated Completion Date: 2026-06
Participants
Target number of participants: 3000
Treatments
1
Sarcoma patients undergoing core biopsy, incisional biopsy or definitive surgical resection for soft tissue masses of extremity, trunk or retroperitoneum
Authors
Singer Singer
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov